Akihiro Shindo
Publication Activity (10 Years)
Years Active: 2017-2022
Publications (10 Years): 7
Publications (10 Years): 7
Publications
- Hidehiro Ishikawa, Caleigh Mandel-Brehm, Akihiro Shindo, Martha A Cady, Sabrina A Mann, Atsushi Niwa, Koichi Miyashita, Yuichiro Ii, Kelsey C Zorn, Akira Taniguchi, Masayuki Maeda, Michael R Wilson, Joseph L DeRisi, Hidekazu Tomimoto
- Naohiro Egawa, Gen Hamanaka, Kelly K Chung, Hidehiro Ishikawa, Akihiro Shindo, Takakuni Maki, Ryosuke Takahashi, Haruhisa Inoue, Eng H Lo, Ken Arai
- Takayuki Kondo, Haruhiko Banno, Taro Okunomiya, Yoko Amino, Kayoko Endo, Akiyoshi Nakakura, Ryuji Uozumi, Akemi Kinoshita, Harue Tada, Satoshi Morita, Hidehiro Ishikawa, Akihiro Shindo, Ken Yasuda, Yosuke Taruno, Takakuni Maki, Takashi Suehiro, Kohji Mori, Manabu Ikeda, Koji Fujita, Yuishin Izumi, Kazutomi Kanemaru, Kenji Ishii, Kazue Shigenobu, Yumiko Kutoku, Yoshihide Sunada, Shinobu Kawakatsu, Shunji Shiota, Toshifumi Watanabe, Osamu Uchikawa, Ryosuke Takahashi, Hidekazu Tomimoto, Haruhisa InoueRepurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations. BMJ open 11 (6) (2021)
- Hidehiro Ishikawa, Akihiro Shindo, Yuichiro Ii, Dai Kishida, Atsushi Niwa, Yamato Nishiguchi, Keita Matsuura, Natsuko Kato, Akane Mizutani, Kei Tachibana, Yoshinori Hirata, Hirofumi Matsuyama, Ai Ogawa-Ito, Akira Taniguchi, Hidekazu Tomimoto
- Kana Matsuda, Masayuki Satoh, Ken-Ichi Tabei, Yukito Ueda, Ai Itoh, Hidehiro Ishikawa, Ko Matsuo, Akihiro Shindo, Masaru Asahi, Atsushi Niwa, Keita Matsuura, Hidekazu Tomimoto
- Hirofumi Matsuyama, Yuichiro Ii, Masayuki Maeda, Maki Umino, Yukito Ueda, Ken-Ichi Tabei, Hirotaka Kida, Masayuki Satoh, Akihiro Shindo, Akira Taniguchi, Ryosuke Takahashi, Hidekazu Tomimoto
- Akitaka Yamamoto, Yukinari Omori, Akihiro Shindo, Hiroshi Imai, Hidenori Suzuki